Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer

Recently, a tumor-autonomous cytochrome P450 (CYP)-3A5-mediated resistance to cancer therapy has been demonstrated in pancreatic ductal adenocarcinoma. Expression of CYP3A5, which is involved in the degradation of irinotecan, has also been reported in colorectal cancer (CRC). The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Buck, Emanuel, Sprick, Martin, Gaida, Matthias M., Grüllich, Carsten, Weber, Tim Frederik, Herpel, Esther, Bruckner, Thomas, Koschny, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403523/
https://www.ncbi.nlm.nih.gov/pubmed/30881507
http://dx.doi.org/10.3892/ol.2019.10043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403523/
https://www.ncbi.nlm.nih.gov/pubmed/30881507
http://dx.doi.org/10.3892/ol.2019.10043

Ejemplares similares